Vision / Mission
Insmed is a research-driven biopharmaceutical company with broad expertise in and innovative approaches to the development of protein-based therapeutics, and efficiently moving product candidates through the regulatory approval process.
The Company's goal is to lead the emerging field of follow-on biologics by creating biosimilar versions of existing protein-based therapies as they come off patent, providing patients around the world with more affordable access to these critical medicines.
Insmed also has a proprietary protein drug development program that targets significant unmet medical needs in the neuromuscular therapeutic area.
How do we achieve our Vision/Mission?
- Position Insmed Therapeutic Proteins as a leader in the evolving follow on biologics market
- Apply our corporate knowledge of therapeutic proteins to the development of key therapies thus expanding access to novel life saving medicines
- Leverage our biologics infrastructure and knowledge capital to produce high quality therapeutic proteins
- Introduce competition to existing monopolies in anemia, neutropenia and MS therefore expanding patient access to these critical therapies
- Continued development of novel therapies for unmet medical needs in neuromuscular diseases
